In fact, miR-663a participates in the process of inhibiting the vascular remodeling in normal pulmonary artery cells and oppressing the creation of pulmonary artery hypertension by inhibiting transforming growth factor-beta (TGF-β) (Li P. et al., 2021). Here, TGFB1 is linked to pulmonary arterial hypertension.